We serve Chemical Name:2-Chloro-5-(4-chlorophenyl)pyridine CAS:76053-48-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Chloro-5-(4-chlorophenyl)pyridine
CAS.NO:76053-48-0
Synonyms:Pyridine,2-chloro-5-(4-chlorophenyl);X3379
Molecular Formula:C11H7Cl2N
Molecular Weight:224.08600
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.89000
Exact Mass:222.99600
LogP:4.05540
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Pyridine,2-chloro-5-(4-chlorophenyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,X3379 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyridine,2-chloro-5-(4-chlorophenyl) Use and application,X3379 technical grade,usp/ep/jp grade.
Related News: Biogen hiked its revenue guidance for the year, saying it expects total sales of $10.65 billion to $10.85 billion this year. That’s up from its previous estimates of $10.45 billion to $10.75 billion. The new forecast assumes “modest” revenue from Aduhelm in 2021, ramping up thereafter, the company said. (E)-3-Fluoro-2-(2,2,2-trichloro-ethoxycarbonylamino)-acrylic acid benzhydryl ester manufacturers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 1-(4-(7-chloroquinolin-4-ylamino)phenyl)-3-phenylprop-2-en-1-one suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. (S)-2-(4,5-dichloro-2-(N-(methylsulfonyl)methylsulfonamido)phenyl)-N-methyl-N-(1-phenyl-2-(pyrrolidin-1-yl)ethyl)acetamide vendor & factory EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions.,Biogen hiked its revenue guidance for the year, saying it expects total sales of $10.65 billion to $10.85 billion this year. That’s up from its previous estimates of $10.45 billion to $10.75 billion. The new forecast assumes “modest” revenue from Aduhelm in 2021, ramping up thereafter, the company said.
